ArticleJournal of cancer research and clinical oncology2023

Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer.

Annabelle Volk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.